# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian epithelial cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 535 results.
Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
Status: Not yet recruiting
Last Changed: Nov 01, 2019
First Received: Jul 18, 2017
Disease(s): Ovarian Epithelial Cancer
Intervention(s): Cytoreductive surgery combined with HIPEC, Chemotherapy and bevacizumab (CT-BEV)
Locations: Centre Hospitalier Universitaire Jean Minjoz, Besançon, France
Centre Hospitalier Universitaire Jean Minjoz, Besançon, France
Centre Oscar Lambret, Lille, France
CHRU Claude Huriez, Lille, France
Centre Léon Bérard, Lyon, France
... and 18 other locations.
Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
Status: Recruiting
Last Changed: Mar 28, 2019
First Received: Jun 20, 2011
Disease(s): Ovarian Epithelial Cancer Recurrent
Intervention(s): Maximal cytoreductive surgery, HIPEC
Locations: Institut Jules Bordet, Brussels, Belgium
CHU d'AMIENS, Amiens, France
Centre Paul Papin, Angers, France
Institut Bergonie, Bordeaux, France
Clinique Pasteur, Brest, France
... and 29 other locations.
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Status: Recruiting
Last Changed: Jul 23, 2019
First Received: Jul 23, 2019
Disease(s): Ovarian Epithelial Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Intervention(s): Gimatecan 0.6mg/m2/d, 0.8mg/m2/d, 0.4mg/m2/d
Locations: Beijing Tumor Hospital, Beijing, Beijing, China
NeoVax With Nivolumab in Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Mar 05, 2020
First Received: Jul 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Nivolumab, NeoVax, Core Needle Biopsy
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: May 22, 2018
Disease(s): Ovarian Cancer
Intervention(s): Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer
Status: Recruiting
Last Changed: Apr 23, 2019
First Received: Apr 23, 2019
Disease(s): Ovarian Cancer
Intervention(s): Anlotinib
Locations: The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer
Status: Recruiting
Last Changed: Oct 18, 2018
First Received: Jul 04, 2016
Disease(s): Ovarian Epithelial Cancer
Intervention(s): Olaparib, carboplatin + gemcitabine or carboplatin + paclitaxel or carboplatin + liposomal doxorubicin or liposomal doxorubicin 4-weekly or topotecan or paclitaxel weekly
Locations: UZLeuven, Leuven, Belgium
Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 03, 2020
First Received: Jan 03, 2020
Disease(s): Ovarian Cancer
Intervention(s): Niraparib
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: Nov 06, 2019
First Received: Aug 21, 2018
Disease(s): Ovarian Cancer
Intervention(s): AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD), Placebo
Locations: Arizona Oncology, Phoenix, Arizona, United States
Kaiser Permanente Oakland, Oakland, California, United States
Stanford University, Palo Alto, California, United States
Kaiser Permanente Roseville, Roseville, California, United States
Kaiser Permanente Sacramento, Sacramento, California, United States
... and 19 other locations.
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
Status: Recruiting
Last Changed: Dec 20, 2019
First Received: May 09, 2019
Disease(s): Ovarian Cancer
Locations: University of New Mexico Cancer Center, Albuquerque, New Mexico, United States